We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
One Year No Beer (OYNB) is a community support platform that helps people change their relationship with alcohol. It does this by allowing its users to choose a plan from the company's subscription-based models that consist of a 28-day, 90-day, and 365-day challenge to stay away from alcohol. The platform has empowered 70,000+ people in 90 countries through its challenges. Excess alcohol consumption leads to 3 million deaths per year and costs up to £59 billion to the UK economy alone. OYNB aims to resolve this crisis through its platform. For its efforts, the platform has been mentioned in publications such as the BBC, ITV, Metro, and Daily Telegraph. It also has an online presence of 130,000+ Facebook and 50,000+ Instagram followers. The company will use 42% of the investment to hire personnel, 33% for technology and product builds, and 25% as overhead costs.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,757,111
TOTM makes organic, eco-friendly & reusable period care products. The company is planning to shake up the £29 billion Femcare industry, with 30k+ online and subscription customers, and listings in Tesco, Superdrug and Urban Outfitters and global B2B clients. Having supplied to large corporates including several global institutions, TOTM is ready for global disruption. To this end, the company is raising funds to accelerate global growth across all channels. The proceeds will also be used to expand its product range, grow awareness, secure more distribution and also invest in tech. 

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £811,400
Improving the railway construction industry by collecting data to reduce inefficiencies and overspending. Rail Diary is a B2B SaaS product that is designed to analyse information on infrastructure projects to improve particular elements that plague the industry. These include the delivery, commercialisation and the health and safety of projects. Rail Diary allows developers to monitor ongoing costs, forecast for the future and reduce the number of claims made. Rail Diary will generate revenue via a monthly subscription model ranging from £45 to £150, plus project fees.
days to go: Expired investment: £50,544
&SISTERS is a femcare company offering products that are hypoallergenic, pH-neutral and free from chlorine, pesticides & perfumes. It has sold 225,000+ certified organic cotton period products, directly to 300+ customers. The company has many listed retailers including Feel Unique, Farmdrop and Triyoga and exports to many countries including Asia and Europe. In January 2020, &SISTERS is planning to launch a new paper-wrapped naked tampon®. With the proceeds, the company will expand the product range, expand the team, raise awareness and accelerate sales.
days to go: Expired investment: £199,630
CoreHaus applies known, tried and tested construction methodology intelligently to meet the growing demand for offsite manufactured housing solutions. Their principles are based on ground and the first floor standardised 'modular cores' which includes a pre-finished kitchen, staircase, central heating and electrical control systems and bathroom. Their product has designed and developed, trademarks and IP's are in place, private sites secured under contract, and they are currently working with some exciting partners and supply chains to roll out the product launch.
days to go: Expired investment: Withheld
Nude is a savings account and financial application designed for ~13 million 18-35-year-olds who want to own a home in the UK. The company is rebuilding the home-buying experience and assist its clients from planning to the move-in stage of home buying. The company has applied for a banking licence to launch Nude mortgages and plans to support people through all of life's big moments, like weddings, children's accounts and retirement plans as well. In 2019, Nude raised £1.7 million and was awarded an innovation grant of ~£440,000 from Scottish Enterprise. The company is registered with the Financial Conduct Authority(FCA) and has 7,500+ subscribers on its newsletter. It will use 50% of the investment to build its savings platform, 20% for operational costs, 20% in marketing initiatives, and 10% in building its data & behavioural science platform. 
days to go: Expired investment: £3,539,200
Noble Tree Property Investment plans to develop, own, let and sell affordable housing and specialty care home developments in the UK with the aim of balancing financial and social returns.
days to go: Expired investment: £1,550
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph